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The proteolytic enzymes, or proteases, that catalyzeProteases: The Tip of the Iceberg
peptide-bond hydrolysis represent one of the largest
known functional classes of proteins. Through the catal-
Proteases of Infectious Agents ysis of an essentially irreversible reaction they regulate
Edited by Ben M. Dunn commitment to such critical tasks as digestion, secre-
San Diego, CA: Academic Press (1999). 282 pp. $69.95 tion, migration, assembly, proliferation, and cell death.
Furthermore, proteolytic mechanisms are well studied
Handbook of Proteolytic Enzymes and elements of a protease's catalytic mechanism can
Edited by Alan J. Barrett, Neil D. Rawlings, be exploited in the drug design process.
and J. Fred Woessner It appears to be against the backdrop of identifying
San Diego, CA: Academic Press (1998). 1666 pp. With new pathogenic targets for drug design that the editor
CD-ROM $250.00 compiled the book Proteases of Infectious Agents. The
contents of this book can be broken down into four
ªIt is the power of man to make parasitic maladies disap- categories: six chapters on proteases involved in viral
pear from the face of the globe.º infection (HIV protease, hepatitis C protease, herpesvi-
ÐLouis Pasteur rus proteases, picornavirus proteases, host viral pro-
cessing proteases, plant virus proteases), two chapters
We live our lives unavoidably bathed in an ocean of on protozoan infection (malarial proteases, Chagas dis-
viruses, bacteria, and parasites. The physical barriers ease proteases), one chapter on fungal infection (Can-
of skin and mucosal membranes and the intricacy of dida proteases), and one chapter on bacterial infection
the immune system allows us to live in peaceful equa- (bacterial signal peptidases). The book was not written
nimity with microbes...for the most part. The delicate as an integrated approach to proteases involved in
nature of the equilibrium between host and microbe has pathogenesis, but rather as separate stand-alone chap-
been evident from the earliest accounts of civilization. ters contributed by researchers in the field. That being
Indeed, the battle between humans and infectious dis- said, a theme that unifies each chapter is not only the
ease has only in this past century been one of tempered presentation of the basic science of proteases involved
success for humans. Attenuation of death from disease in particular infectious diseases but also the possible
has been due to an increased understanding of infec- therapeutic consequences of protease inhibition. While
tious agents and their modes of transmission as well as the focus on drug design is not evident from the title,
the identification of successful treatments. Introduction Proteases of Infectious Agents, it becomes very obvious
of physical processes like pasteurization, plastered after reading the last sentence of the preface: ªThe task
walls, and condoms significantly reduced the incidence before us is clear: Find the critical protease and develop
of tuberculosis, Chagas disease, and sexually transmit- a potent and selective inhibitor.º (p. xvii). The emphasis
ted diseases, respectively. The identification and devel- of therapeutic intervention through protease inhibition
opment of antibiotics in the early half of the twentieth works better for some of the chapters than for others.
century led many to proclaim that the book was closing The theme of drug design is unmistakable in the chap-
on infectious disease. Despite these advances, infec- ter on HIV protease, the first and longest chapter in the
tious disease has not been eradicated, in fact, 25% of book. In many ways, devoting one-fifth of the book to
all deaths are still attributed to infectious disease (The HIV protease is justifiable; the success of drugs de-
World Health Report, 1999). Worse still is the resistance signed and targeted against this enzyme has fueled in-
of pathogens to drugs that once held them in check. terest for proteases as drug targets. Like many viruses,
The reemergence of tuberculosis as a major health prob- successful replication of HIV requires the proteolytic
lem is due to the increasing resistance of the mycobac- processing of multiple sites in the polyprotein encoded
terium to antibiotics. Malaria is becoming prevalent once by the viral genome. Deletion of the virally encoded HIV
protease gene results in noninfectious virus particles,again due to its ability to evade current antimalarial
drugs and the list of drug-resistant infectious agents demonstrating the essential nature of the proteolytic
activity and validating it as a target for drug design. Thegrows longer every day. The rapid replication times of
microbes make the occurrence of drug resistance seem historical and structural presentation of the drug design
efforts against HIV protease is beautifully presented andinevitable. Indeed, it has been estimated that every sin-
gle point mutation of the HIV genome occurs between well referenced in the book. Ultimately, one of the big-
gest issues permeating the long-term usefulness of any104 and 105 number of times each day in an HIV-infected
individual (J. M. Coffin Science 267, 483±489, 1995). antiviral therapy is drug resistance. The high mutability
of HIV means that drug design efforts against viral en-Therefore, the rapid evolution of HIV results in it sur-
mounting obstacles in an expansive manner. But like zymes inevitably have to aim at moving targets. How-
ever, there may be limits to the mutational accessibilitythe turtle and the hare, faster is not always better.
While the battle against microbes may never be won, of the protease for maintaining activity and substrate
specificity while escaping drug inhibition. While the au-keeping them at bay requires disruption of essential
processes in the pathogen life cycle. One class of pro- thors present what is known about resistance, even of-
fering some potential strategies to combat it, they truth-teins that has recently become an attractive target for
therapeutic intervention is that of proteolytic enzymes. fully state that ªthe full implications of resistance for
disease outcome have not yet been realizedº (p. 36).Cleavage of the peptide bond is a reaction that is vital
in almost every aspect of life for both host and pathogen. The immune compromising effects of HIV infection
have given rise to an increase in opportunistic patho-The peptide bond has a half-life of seven and a half
years and requires selective catalysis to hydrolyze it. gens such as the Candida and human herpesviruses,
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both discussed in the book. Various Candida species Barrett, Rawlings, and Woessner who edited the mam-
express and secrete a family of aspartyl proteases that moth Handbook of Proteolytic Enzymes. It provides a
have been implicated as virulence factors. Characteriza- much needed classification system to help organize the
tion and structural determination of the protease en- relationship amoung each of the members. The short
coded by several herpesviruses reveal a unique catalytic chapters on the individual proteases are uniform and
mechanism and a novel protein fold not previously seen well organized starting with classification and databank
in mammalian proteases. Other examples of non-host- identifiers of the protease followed by sections on its
like proteases are discussed in the book, such as the history, activity and substrate specificity, structure,
hepatitis C protease's unusual requirement for a peptide preparation, biology, distinguishing features, related
cofactor. These may be examples of the viruses being proteases, and references. The accompanying CD-ROM
too smart for their own good. The novelty of the protease not only provides the text and figures of the handbook in
folds and mechanisms allows for the design of drugs a completely searchable format but there are additional
that distinguish viral proteases from host proteases and sequence alignments, three-dimensional structures, and
may, in the end, be the Achilles' heel of the virus. cross-references to links on the world wide web. The
But the host's proteases are not always innocent. An Handbook of Proteolytic Enzymes is an important piece
additional aspect of viral infection is the role of host of literature and absolutely indispensable for those
proteases in determining the infectivity and tropism of working in the field of proteolysis.
certain viruses. Evidence for the assistance of a host For those interested in a comprehensive description
protease, tryptase clara, in the cleavage and activation of proteases, the Handbook of Proteolytic Enzymes is
of the fusion glycoprotein of Sendai virus or the hem- an excellent resource. For a more in-depth view of the
magglutinin of the influenza virus is presented. Tryptase involvement of proteases in specific infectious diseases
clara is only expressed in the epithelial cells of the respi- and drug design strategies to combat them, Proteases
ratory tract and therefore might explain the localization of Infectious Agents offers current and detailed analysis.
of the virus to these cells. The editors of the Handbook of Proteolytic Enzymes
Chapters on malaria and Chagas disease represent point out that an estimated 2% of genes in a genome
infectious disease caused by protozoa. These protozoa encode proteases. Although not all of these proteases
have complex life cycles involving multiple stages and will be attractive targets for drug design, Proteases of
transmission through an insect vector. Proteases are Infectious Agents shows us that we could be looking at
postulated to play various roles in the parasite life cycle, the tip of the iceberg. Given the emergence and reemer-
from invasion to differentiation to digestion. The omni- gence of infectious agents, these books offer a timely
presence of proteases in the parasitic life cycle makes look at a class of enzymes that may yield weapons in
them attractive targets for drug design. However, the our arsenal to contain disease.
role of individual proteases has been implied from inhibi-
tor studies and has not been conclusively established Jennifer L. Harris and Charles S. Craik
in these systems. Unlike most viral proteases, the down- Department of Pharmaceutical Chemistry
stream substrates of many parasitic proteases are not Graduate Group in Chemistry and Chemical Biology
known. Identification of the pathways they operate in University of California, San Francisco
may lead to additional avenues for therapeutic inter- San Francisco, California 94143
vention.
Resistance to antibiotics represents a major public
health issue. A novel bacterial target presented in the
book, Proteases of Infectious Agents, is the type I signal
peptidase. This protease is pivotal to the exportation of
proteins from the cytoplasm since removal of the signal
peptide is required for proper release of the secreted
protein as well as for proper localization of membrane
proteins with cleaved signal peptides. The enzyme is
essential for bacterial viability. The drug design process
may be hampered by cross-reactivity with the host mi-
crosomal signal peptidases that appear to be distant
relatives of the bacterial peptidase. Nonetheless, this
target holds promise for a new class of broad spectrum
antibiotics, particularly with the availability of key crystal
structures and mechanistic information of various mem-
bers of the family of signal peptidases forthcoming.
While several classes of infectious agents and the
proteases they use to facilitate infection are discussed
in Proteases of Infectious Agents, the editor does not
claim it to be encyclopedic, and it is not. A comprehen-
sive assembly of proteases, even narrowed down to
pathogenic proteases, into a single handbook is a daunt-
ing task due to the sheer numbers of proteases. How-
ever, this heroic task of collecting and compiling infor-
mation on over 500 proteases has been taken on by
